Capital markets continued to gyrate in April. We used the correction to add new positions and correspondingly reduced our cash weighting. An overview of the performance of our actively-managed products is as follows:
- The AFINA Optima10 was down 1.1% in April. The Optima10 is now fully invested with a 5% cash weighting and a 3.64% dividend yield. Consumer/health care stocks accounted for a 38.0% weighting, financials represented 47.5% and technology was 9.5%.
- The AFINA Affinity was down 0.9% in April. The Affinity now has a 18.0% cash weighting and a 2.74% dividend yield. Consumer/health care stocks accounted for a 35.0% weighting, financials represented 34.0% and technology was 10.0%.
|Instruments (% return)||Apr 2018||2018||2017||2016|
As of April 30, 2018. All figures are net of fees and other expenses. Past performance is not indicative of future results. Refer to https://www.afinacapital.com/legal/ for full details and disclosures.
(1) The benchmark represents a 50% weighting of the S&P 500 Total Return Index in Canadian dollars and a 50% weighting of the S&P/TSX Composite Total Return Index in Canadian dollars.